|
1
|
Li J, Yen C, Liaw D, Podsypanina K, Bose
S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, et al:
PTEN, a putative protein tyrosine phosphatase gene mutated in human
brain, breast, and prostate cancer. Science. 275:1943–1947. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hollander MC, Blumenthal GM and Dennis PA:
PTEN loss in the continuum of common cancers, rare syndromes and
mouse models. Nat Rev Cancer. 11:289–301. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rasheed BK, Stenzel TT, McLendon RE,
Parsons R, Friedman AH, Friedman HS, Bigner DD and Bigner SH: PTEN
gene mutations are seen in high-grade but not in low-grade gliomas.
Cancer Res. 57:4187–4190. 1997.PubMed/NCBI
|
|
4
|
Eng C: PTEN: One gene, many syndromes. Hum
Mutat. 22:183–198. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Feng J, Liang J, Li J, Li Y, Liang H, Zhao
X, McNutt MA and Yin Y: PTEN controls the DNA replication process
through MCM2 in response to replicative stress. Cell Rep.
13:1295–1303. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shen WH, Balajee AS, Wang J, Wu H, Eng C,
Pandolfi PP and Yin Y: Essential role for nuclear PTEN in
maintaining chromosomal integrity. Cell. 128:157–170. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kang X, Song C, Du X, Zhang C, Liu Y,
Liang L, He J, Lamb K, Shen WH and Yin Y: PTEN stabilizes TOP2A and
regulates the DNA decatenation. Sci Rep. 5:178732015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang G, Li Y, Wang P, Liang H, Cui M, Zhu
M, Guo L, Su Q, Sun Y, McNutt MA and Yin Y: PTEN regulates RPA1 and
protects DNA replication forks. Cell Res. 25:1189–1204. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Stiles B, Wang Y, Stahl A, Bassilian S,
Lee WP, Kim YJ, Sherwin R, Devaskar S, Lesche R, Magnuson MA and Wu
H: Liver-specific deletion of negative regulator Pten results in
fatty liver and insulin hypersensitivity [corrected]. Proc Natl
Acad Sci USA. 101:2082–2087. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Knafo S, Sanchez-Puelles C, Palomer E,
Delgado I, Draffin JE, Mingo J, Wahle T, Kaleka K, Mou L,
Pereda-Perez I, et al: PTEN recruitment controls synaptic and
cognitive function in Alzheimer's models. Nat Neurosci. 19:443–453.
2016. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li S, Zhu M, Pan R, Fang T, Cao YY, Chen
S, Zhao X, Lei CQ, Guo L, Chen Y, et al: The tumor suppressor PTEN
has a critical role in antiviral innate immunity. Nat Immunol.
17:241–249. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Arthur JR and Beckett GJ: Thyroid
function. Br Med Bull. 55:658–668. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang J and Lazar MA: The mechanism of
action of thyroid hormones. Annu Rev Physiol. 62:439–466. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yen PM: Physiological and molecular basis
of thyroid hormone action. Physiol Rev. 81:1097–1142. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mounika B, Brahmaiah B, Ramesh M,
Bhavaneswari K, Anantha Lakshmi T and Nama S: Review on thyroid
disorders. Int J Pharma Res Biosci. 2:197–214. 2013.
|
|
16
|
Lim H, Devesa SS, Sosa JA, Check D and
Kitahara CM: Trends in thyroid cancer incidence and mortality in
the United States, 1974–2013. JAMA. 317:1338–1348. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dahia PL, Marsh DJ, Zheng Z, Zedenius J,
Komminoth P, Frisk T, Wallin G, Parsons R, Longy M, Larsson C and
Eng C: Somatic deletions and mutations in the Cowden disease gene,
PTEN, in sporadic thyroid tumors. Cancer Res. 57:4710–4713.
1997.PubMed/NCBI
|
|
18
|
Halachmi N, Halachmi S, Evron E, Cairns P,
Okami K, Saji M, Westra WH, Zeiger MA, Jen J and Sidransky D:
Somatic mutations of the PTEN tumor suppressor gene in sporadic
follicular thyroid tumors. Genes Chromosomes Cancer. 23:239–243.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yeh JJ, Marsh DJ, Zedenius J, Dwight T,
Delbridge L, Robinson BG and Eng C: Fine-structure deletion mapping
of 10q22-24 identifies regions of loss of heterozygosity and
suggests that sporadic follicular thyroid adenomas and follicular
thyroid carcinomas develop along distinct neoplastic pathways.
Genes Chromosomes Cancer. 26:322–328. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bruni P, Boccia A, Baldassarre G, Trapasso
F, Santoro M, Chiappetta G, Fusco A and Viglietto G: PTEN
expression is reduced in a subset of sporadic thyroid carcinomas:
Evidence that PTEN-growth suppressing activity in thyroid cancer
cells mediated by p27kip1. Oncogene. 19:3146–3155. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gimm O, Perren A, Weng LP, Marsh DJ, Yeh
JJ, Ziebold U, Gil E, Hinze R, Delbridge L, Lees JA, et al:
Differential nuclear and cytoplasmic expression of PTEN in normal
thyroid tissue, and benign and malignant epithelial thyroid tumors.
Am J Pathol. 156:1693–1700. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Di Loreto C, Tell G, Pestrin M, Pandolfi
M, Damante G and Puglisi F: PTEN and Egr-1 expression in thyroid
proliferative lesions. Cancer Lett. 224:105–109. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Farooq A, Walker LJ, Bowling J and Audisio
RA: Cowden syndrome. Cancer Treat Rev. 36:577–583. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yeager N, Klein-Szanto A, Kimura S and Di
Cristofano A: Pten loss in the mouse thyroid causes goiter and
follicular adenomas: Insights into thyroid function and Cowden
disease pathogenesis. Cancer Res. 67:959–966. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dahl E, Koseki H and Balling R: Pax genes
and organogenesis. Bioessays. 19:755–765. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Plachov D, Chowdhury K, Walther C, Simon
D, Guenet JL and Gruss P: Pax8, a murine paired box gene expressed
in the developing excretory system and thyroid gland. Development.
110:643–651. 1990.PubMed/NCBI
|
|
27
|
Mansouri A, Chowdhury K and Gruss P:
Follicular cells of the thyroid gland require Pax8 gene function.
Nat Genet. 19:87–90. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pasca di Magliano M, Di Lauro R and
Zannini M: Pax8 has a key role in thyroid cell differentiation.
Proc Natl Acad Sci USA. 97:13144–13149. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Damante G and Di Lauro R: Thyroid-specific
gene expression. Biochim Biophys Acta. 1218:255–266. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Carrasco N: Iodide transport in the
thyroid gland. Biochim Biophys Acta. 1154:65–82. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tiozzo C, Danopoulos S, Lavarreda-Pearce
M, Baptista S, Varimezova R, Al Alam D, Warburton D, Virender R, De
Langhe S, Di Cristofano A, et al: Embryonic epithelial Pten
deletion through Nkx2.1-cre leads to thyroid tumorigenesis in a
strain-dependent manner. Endocr Relat Cancer. 19:111–122. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mauchamp J, Mirrione A, Alquier C and
André F: Follicle-like structure and polarized monolayer: Role of
the extracellular matrix on thyroid cell organization in primary
culture. Biol Cell. 90:369–380. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Koumarianou P, Goméz-López G and
Santisteban P: Pax8 controls thyroid follicular polarity through
cadherin-16. J Cell Sci. 130:219–231. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Nitsch L, Tramontano D, Ambesi-Impiombato
FS, Quarto N and Bonatti S: Morphological and functional polarity
of an epithelial thyroid cell line. Eur J Cell Biol. 38:57–66.
1985.PubMed/NCBI
|
|
35
|
Macchia PE, Lapi P, Krude H, Pirro MT,
Missero C, Chiovato L, Souabni A, Baserga M, Tassi V, Pinchera A,
et al: PAX8 mutations associated with congenital hypothyroidism
caused by thyroid dysgenesis. Nat Genet. 19:83–86. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Riesco-Eizaguirre G, Wert-Lamas L,
Perales-Patón J, Sastre-Perona A, Fernández LP and Santisteban P:
The miR-146b-3p/PAX8/NIS regulatory circuit modulates the
differentiation phenotype and function of thyroid cells during
carcinogenesis. Cancer Res. 75:4119–4130. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mascia A, Nitsch L, Di Lauro R and Zannini
M: Hormonal control of the transcription factor Pax8 and its role
in the regulation of thyroglobulin gene expression in thyroid
cells. J Endocrinol. 172:163–176. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
de Cristofaro T, Mascia A, Pappalardo A,
D'Andrea B, Nitsch L and Zannini M: Pax8 protein stability is
controlled by sumoylation. J Mol Endocrinol. 42:35–46. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Stuart ET and Gruss P: PAX: Developmental
control genes in cell growth and differentiation. Cell Growth
Differ. 7:405–412. 1996.PubMed/NCBI
|
|
40
|
Targovnik HM, Citterio CE and Rivolta CM:
Iodide handling disorders (NIS, TPO, TG, IYD). Best Pract Res Clin
Endocrinol Metab. 31:195–212. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Long W, Lu G, Zhou W, Yang Y, Zhang B,
Zhou H, Jiang L and Yu B: Targeted next-generation sequencing of
thirteen causative genes in Chinese patients with congenital
hypothyroidism. Endocr J. 65:1019–1028. 2018. View Article : Google Scholar : PubMed/NCBI
|
